Understanding Updates in the Vaccination Environment: Regulatory and Clinical Updates for the 65+ PopulationAugust 29, 2023
Stephen Creasy, PharmD, Director of Clinical Services, PharMerica
Date: Tuesday, August 29, 2023
Time: 1:00pm ET
In its October 2022 meeting, the Advisory Committee on Immunization Practices (ACIP) approved the Recommended Adult Immunization Schedule for 2023. In this discussion, we will cover notable changes to vaccine schedules, what facilities can expect regarding the regulatory landscape, as well as how these updates will impact individuals 65 years and older. We will also explore the new preference given to 3 select versions of the influenza vaccine: high-dose inactivated influenza vaccine, quadrivalent recombinant influenza vaccine, and quadrivalent adjuvanted inactivated influenza vaccine.
- Review significant vaccine regulatory updates over the past year.
- Understand the vaccine schedule changes with impact to the older population.
- Learn about new vaccines with utility in the older population.
This program was approved for 1 participant CE credit hour by NAB/NCERS, approval code 20240828-1-A95658-DL. Attendees must have been in live attendance for at least 50 minutes to receive credit.